Novo Nordisk A/S - Page 2

‘Miracle drug’ euphoria: Professionals warn in style use of weight reduction drugs faces primary hurdles

Two mavens see primary demanding situations going through the adoption of latest weight problems medication.Dr. Kavita Patel, a doctor and NBC Information clinical contributor, believes contemporary knowledge from Novo Nordisk on Ozempic’s

October 14, 2023

OpenAI

Novo Nordisk's Wegovy wins FDA acclaim for reducing center illness dangers, in transfer that might increase insurance plans

The approval additionally demonstrates that weight reduction medicine have vital well being advantages past dropping undesirable kilos and regulating blood sugar. Wegovy is now the primary weight reduction drugs to realize expanded

March 8, 2024

Business

Viking Therapeutics’ inventory doubles after corporate studies certain ends up in trial of weight-loss drug

Viking Therapeutics Inc.’s inventory soared 100% early Tuesday, after the corporate introduced certain effects from a Section 2 trial of its weight-loss drug VK2735, a GLP-1 receptor agonist that it’s growing in

February 27, 2024

Business

Novo Nordisk and Eli Lilly rival soars 32% after promising weight-loss drug effects

Vials transfer alongside a conveyor on the Novo Nordisk A/S manufacturing amenities in Hillerod, Denmark, on Monday, June 12, 2023. The luck of Novo’s bestsellers Ozempic and Wegovy, medication that lend a

February 26, 2024

Business

Novo Nordisk’s market value reaches 0 billion as demand for Wegovy and Ozempic surges

Novo Nordisk’s market value reaches $500 billion as demand for Wegovy and Ozempic surges

Liselotte Sabroe | Afp | Getty ImagesFull-year operating profit soared by 37% in kroner and 44% at constant exchange rates to 102.6 billion kroner. The Danish pharmaceutical giant anticipates sales growth of

January 31, 2024

Business

European stocks set for varied start as markets anticipate Fed decision

Novo Nordisk surpasses predictions amid weight-loss drug successStock Chart IconStock chart iconImage of the Novo Nordisk share price.Novo Nordisk announced on Wednesday that its drugs Ozempic and Wegovy, used for diabetes and

January 31, 2024

Business

Weight reduction medication, Alzheimer's remedies and gene modifying: Monumental firsts outlined 2023 in pharma

Soumyabrata Roy | Nurphoto | Getty ImagesThe Alzheimer’s illness house additionally were given various consideration, with the approval and release of the first-ever remedy confirmed to sluggish the development of the memory-robbing

December 20, 2023

Business

Pfizer’s twice-daily weight reduction tablet joins a protracted checklist of weight problems drug flops

Pfizer’s twice-daily model of its experimental weight reduction tablet has now joined a protracted checklist of alternative scrapped weight problems medication. Pfizer’s transfer to drop two weight problems drug applicants within the remaining

December 2, 2023

Business

Pfizer to discontinue twice-daily weight reduction tablet because of excessive charges of difficult uncomfortable side effects

Pfizer stated it could prevent creating the twice-daily model of its experimental weight reduction tablet after overweight sufferers taking the drug misplaced weight however had bother tolerating the drug in a mid-stage

December 1, 2023

Business

5 issues to grasp ahead of the inventory marketplace opens Monday

Buyers hope U.S. shares will maintain a profitable streak after Moody’s minimize its U.S. credit score outlook.Congress is making an attempt to stop a central authority shutdown ahead of the top of

November 13, 2023

Business

Cramer’s week forward: Shopper spending within the highlight with retail income and a brand new worth index

CNBC’s Jim Cramer on Friday highlighted subsequent week’s notable information and income reviews on Wall Boulevard’s radar.He’s going to be observing for brand spanking new shopper worth index figures in addition to

November 11, 2023

Business

Previous 1 2 3 Next

Novo Nordisk A/S - Page 2

‘Miracle drug’ euphoria: Professionals warn in style use of weight reduction drugs faces primary hurdles

Novo Nordisk and Eli Lilly rival soars 32% after promising weight-loss drug effects

Novo Nordisk’s market value reaches $500 billion as demand for Wegovy and Ozempic surges

European stocks set for varied start as markets anticipate Fed decision

Weight reduction medication, Alzheimer's remedies and gene modifying: Monumental firsts outlined 2023 in pharma

Pfizer to discontinue twice-daily weight reduction tablet because of excessive charges of difficult uncomfortable side effects

5 issues to grasp ahead of the inventory marketplace opens Monday

Cramer’s week forward: Shopper spending within the highlight with retail income and a brand new worth index

Recent Posts

Categories

Suggestions

Novo Nordisk A/S - Page 2

Recent Posts

Categories